Shoulders and Elbows

TRB Chemedica (UK) Ltd supported another event this summer related to sports medicine: the BESS Annual Scientific Meeting held in Torquay (15-17 June 2012). BESS stands for British Elbow and Shoulder Society.

The annual meeting in June attracted many delegates from all parts of the UK, to attend lectures and seminars on the techniques and latest developments in shoulder and elbow surgery and other treatment options.

TRB Chemedica (UK) Ltd had a stand at the trade exhibition during the congress, and TRB staff talked to many stand visitors about the benefits of sodium hyaluronate treatments for traumatic and degenerative joint disease in the shoulder and elbow.

OSTENIL^® is the only Sodium Hyaluronate product recommended in the formulary for the world-wide sports event in England this year. This fact, coupled with the experience that many of the delegates already had with OSTENIL^® and OSTENIL^® PLUS, helped to promote the OSTENIL^® range as a valid treatment option.

OSTENIL^® and OSTENIL^® PLUS come in the form of syringes which can be injected into the synovial joint either to prevent or to postpone surgery.

Sodium hyaluronate can also be used post-arthroscopy: VISCOSEAL^® replaces the lost synovial fluid that was washed out during the arthroscopic procedure and helps to promote joint homeostasis.

We look forward to supporting other conferences later on in 2012 where we can talk to sports physicians and medical specialists about the benefits of the OSTENIL^® range, and on how it can help rehabilitate our sporting champions.

New Packaging

We at TRB Chemedica are currently in the process of updating the packaging of our products. Our customers will have already noticed the new Vismed multi bottle which now comes in a new easy-to-use "Just squeeze" dispenser bottle. Vismed single-dose vials as well as Vismed light have also changed their appearance. Vismed gel will follow in 2-3 months' time.

In the orthopaedic product range used for the treatment of osteoarthritis, Ostenil Plus and Ostenil mini have also been transformed in appearance, with Ostenil to follow shortly. Ostenil Tendon is an exciting new product used for the treatment of tendinitis and already reflects the new packaging style.

Last but not least, Viscoseal now comes in a totally new presentation: in syringe form, which makes it easier to handle in the operating theatre.
Visit our website or contact us on info@trbchemedica.co.uk for more details.

Sports Rehab & Trauma Conference 2012

Sports Rehab & Trauma Conference 2012

With the biggest sporting tournament on Earth about to come to London in the summer, there has been enormous interest from medical, surgical and rehabilitation specialists in the UK as to what tips and techniques clinical specialists from around the world might have to offer when it comes to keeping their athletes in tip top form.

At a very busy sports medicine and trauma meeting, held at Chelsea Football Club’s Stamford Bridge Football Ground, over 1000 delegates from all over Europe listened to presentations and seminars, given by some of the world’s leading sports physicians and surgeons, on rehabilitating sporting champions when they have picked up injuries.

The Isokinetic (International Conference on Sports Rehab’ and Trauma), which ran over 2 days (21-22 April 2012) was supported by TRB Chemedica (UK) Ltd, who had a trade exhibition stand at the event. Many of the problems raised by delegates visiting the stand related to maintaining optimum performance for athletes during arduous competitive seasons.  Traumatic and degenerative changes in articular joints are very common amongst top athletes, irrespective of which sport they play. Relieving pain and enhancing range of motion in articular joints are key factors in helping get these athletes back to peak form, and this was a theme that came up regularly in all the key presentations throughout the meeting.

The Ostenil Range of non-animal derived Sodium Hyaluronate injections, manufactured by TRB Chemedica, are specifically designed and licensed for the treatment of traumatic and degenerative changes in synovial joints. Not surprisingly, many of the specialist medical and physiotherapy delegates stated they already had experience with Ostenil and Ostenil Plus, and the fact that Ostenil is the only Sodium Hyaluronate product recommended in the formulary for the up - coming games reinforced their trust in the product range.

TRB Chemedica (UK) Ltd will be attending a host of sports medicine and surgical meetings throughout the rest of 2012, and our staff look forward to speaking with medical and rehabilitation specialists about the Ostenil range, and how it can help keep their patients at the top of their game!

Viscoseal Roundtable Meeting

Synovial fluid replacement after arthroscopy

Arthroscopic procedures in shoulder, knee and hip are nowadays established as minimally invasive methods. However, post-operative pain, swelling and restricted mobility induced by tissue lesion cannot be completely avoided. Those post-operative symptoms can be alleviated with VISCOSEAL®, a solution of hyaluronic acid.

In January of 2011, Dr S Egger (Austria), Dr Muthu Jeyam (UK), Prof C Erggelet (Switzerland) and Dr W Weissenbacher (Austria) gathered together in Austria for a roundtable meeting, to discuss their experiences in arthroscopic surgery. A report on this meeting is now available on our website. Click here to read more...>>> 

New Vismed multi 'Just Squeeze' bottle out now!

TRB Chemedica (UK) Ltd, supplier of sodium hyaluronate based ophthalmic eye products in the UK and Ireland, announces the launch of the new VISMED® MULTI fitted with the innovative and patented preservative-free multi-dose Ophthalmic Squeeze Dispenser (OSD) for the treatment of dry eye. Dry eye patients regularly instil lubricant eye drops, and often do so for the rest of their lives. Many of these patients are elderly and can experience difficulties when using preservative-free multi-dose dispensers, as currently available dispensing systems do not offer overall satisfaction for eye drop delivery. The OSD squeezable dispenser - the result of more than 10 years of research and development in the delivery of preservative-free ophthalmic solutions - highlights the following features :     1) intrinsic intuitiveness of a squeezable container,     2) user friendliness for all adult age groups due to a low actuation force,     3) precise and reproducible drop ejection,     4) ergonomic and pocket size design. VISMED® MULTI is a patented, preservative free, sterile, hypotonic lubricant eye drop formulation of 0.18 % sodium hyaluronate with essential ions (calcium, magnesium, and potassium). The new dispenser contains 10ml of solution, equivalent to more than 250 drops, and remains sterile for up to  3 months after first use. TRB Chemedica (UK) Ltd’s MD, Peter Hunt, stated that “The new VISMED® MULTI ‘Just Squeeze’ bottle will be very well received by both patients and medical professionals.” The worldwide trend towards preservative-free, multi-dose dispensers, which are safe, patient-friendly and cost-effective,  like the OSD system, resonates with TRB Chemedica’s commitment to maintain VISMED® MULTI’s status as the gold standard in lubricant eye drops.

VISMED^® MULTI is still available on the NHS (FP10), as are the other two preservative-free eye drops, VISMED^® and VISMED^® Gel.